Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: April 2022

GreenBox POS (NASDAQ: GBOX) Furthers Growth Strategy with Acquisition of Billion-Dollar Merchant Portfolio

GreenBox has secured an estimated $1 billion merchant accounts portfolio following the closing of an asset purchase agreement with Sky Financial & Intelligence The company reported approximately $2 billion in total processing volume for the full year 2021, meaning the … Continue reading

Posted in GreenBox POS. GBOX | Leave a comment

MissionIRNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) to Present at Planet MicroCap Showcase 2022

Nemaura Medical (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs. The company today announced that it will be presenting at the Planet MicroCap Showcase 2022, which is slated to … Continue reading

Posted in Nemaura Medical Inc. NMRD | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Progress, EV Vision Featured in The Buzz EV News Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that the company was featured in a recently published article by The Buzz EV News that highlights Mullen’s progress and its plans for the upcoming FIVE EV Crossover. … Continue reading

Posted in Mullen Automotive Inc. MULN | Leave a comment

Knightscope, Inc. (NASDAQ: KSCP) Capitalizes on Expanding Security Robot Market; Deploys K5 Model in Charlotte, NC

Each autonomous security robot subscription comes with the Knightscope Security Operations Center (“KSOC”), which provides service opportunities, including recording/streaming, people detection, facial recognition, thermal anomaly detection, license plate recognition, and more Interested users can see the technology first-hand by visiting … Continue reading

Posted in Knightscope Inc. KSCP | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Advancing DehydraTECH-Nicotine Research to Support Safer, More Effective Oral Alternative to Harmful Pulmonary Administration Practices

Lexaria expects to begin dosing this summer as part of a human nicotine study, NIC-H22-1, to compare DehydraTECH-nicotine pouch performance to that of existing leading brands such as ON! and Zyn So far, the company’s animal studies have evidenced that … Continue reading

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Well Positioned for Opportunity

Flora Growth Corp. (NASDAQ: FLGC) has expanded its portfolio, which spans a range of verticals and diverse revenue streams, with growth largely driven through mergers and acquisitions (“M&As”). With M&As defining its 2021 calendar year, Flora Growth capitalized on global … Continue reading

Posted in Flora Growth Corp. FLGC | Leave a comment

MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Poised Amid Strong Support for Nuclear Energy

Energy Fuels (NYSE American: UUUU) (TSX: EFR) is well positioned as clean energy has become a top priority worldwide. A recent article discussing this shines the spotlight on Capitol Hill and strong bipartisan support for nuclear energy. Energy Fuels, a … Continue reading

Posted in Energy Fuels Inc. UUUU | Leave a comment

MissionIRNewsBreaks – GreenBox POS (NASDAQ: GBOX) Committed to Becoming Global Leader in Digital Financial Solutions Marketplace

GreenBox (NASDAQ: GBOX), an innovative blockchain ledger fintech company, recently announced its financial results for the three months ended Dec. 31, 2021, (“Q4 FY2021”) and the fiscal year 2021 (“FY2021”). “GreenBox achieved record revenue in 2021 of $26.3 million, an … Continue reading

Posted in GreenBox POS. GBOX | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Focused on Advancing Research on Treatments for GBM, Other Cancers

CNS Pharmaceuticals (NASDAQ: CNSP) is leading the charge toward advancing research on the treatment for glioblastoma multiforme (“GBM”) as well as other primary and metastatic brain and CNS cancers. Last year, the company commenced a potentially pivotal clinical trial of … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at KCSA Psychedelics Virtual Investor Conference

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO Doug Drysdale will present at the KCSA Psychedelics Virtual Investor Conference. Drysdale’s presentation is slated to begin at 11:00 a.m. … Continue reading

Posted in Cybin Inc. CYBN | Leave a comment